Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension

We show that spironolactone use was associated with an increased rate of all-cause hospitalizations, but no difference in hospitalizations for heart failure or pulmonary arterial hypertension, in patients with World Health Organization Group 1 pulmonary arterial hypertension. A possible reason for t...

Descrizione completa

Dettagli Bibliografici
Autori principali: Morgan E. Corkish, Lauren T. Devine, Megan M. Clarke, Brian P. Murray, Lisa J. Rose-Jones
Natura: Articolo
Lingua:English
Pubblicazione: Wiley 2019-08-01
Serie:Pulmonary Circulation
Accesso online:https://doi.org/10.1177/2045894019868422